302 related articles for article (PubMed ID: 34208521)
1. Prostate Cancer Dormancy and Reactivation in Bone Marrow.
Singh DK; Patel VG; Oh WK; Aguirre-Ghiso JA
J Clin Med; 2021 Jun; 10(12):. PubMed ID: 34208521
[TBL] [Abstract][Full Text] [Related]
2. Disseminated cancer cells in breast cancer: Mechanism of dissemination and dormancy and emerging insights on therapeutic opportunities.
Ramamoorthi G; Kodumudi K; Gallen C; Zachariah NN; Basu A; Albert G; Beyer A; Snyder C; Wiener D; Costa RLB; Czerniecki BJ
Semin Cancer Biol; 2022 Jan; 78():78-89. PubMed ID: 33626407
[TBL] [Abstract][Full Text] [Related]
3. How much do we know about the metastatic process?
Rodriguez-Tirado C; Sosa MS
Clin Exp Metastasis; 2024 Mar; ():. PubMed ID: 38520475
[TBL] [Abstract][Full Text] [Related]
4. 5-Azacytidine- and retinoic-acid-induced reprogramming of DCCs into dormancy suppresses metastasis via restored TGF-β-SMAD4 signaling.
Singh DK; Carcamo S; Farias EF; Hasson D; Zheng W; Sun D; Huang X; Cheung J; Nobre AR; Kale N; Sosa MS; Bernstein E; Aguirre-Ghiso JA
Cell Rep; 2023 Jun; 42(6):112560. PubMed ID: 37267946
[TBL] [Abstract][Full Text] [Related]
5. The Relationship Between Dormant Cancer Cells and Their Microenvironment.
Linde N; Fluegen G; Aguirre-Ghiso JA
Adv Cancer Res; 2016; 132():45-71. PubMed ID: 27613129
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic plasticity in metastatic dormancy: mechanisms and therapeutic implications.
Robinson NJ; Parker KA; Schiemann WP
Ann Transl Med; 2020 Jul; 8(14):903. PubMed ID: 32793747
[TBL] [Abstract][Full Text] [Related]
7.
Montagner M; Sahai E
Front Cell Dev Biol; 2020; 8():37. PubMed ID: 32195244
[TBL] [Abstract][Full Text] [Related]
8. Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII-p38MAPK-pS249/T252RB Pathway.
Yu-Lee LY; Yu G; Lee YC; Lin SC; Pan J; Pan T; Yu KJ; Liu B; Creighton CJ; Rodriguez-Canales J; Villalobos PA; Wistuba II; de Nadal E; Posas F; Gallick GE; Lin SH
Cancer Res; 2018 Jun; 78(11):2911-2924. PubMed ID: 29514796
[TBL] [Abstract][Full Text] [Related]
9. Dormancy and cancer stem cells: An enigma for cancer therapeutic targeting.
Talukdar S; Bhoopathi P; Emdad L; Das S; Sarkar D; Fisher PB
Adv Cancer Res; 2019; 141():43-84. PubMed ID: 30691685
[TBL] [Abstract][Full Text] [Related]
10. Technical Advancements for Studying Immune Regulation of Disseminated Dormant Cancer Cells.
Ombrato L; Montagner M
Front Oncol; 2020; 10():594514. PubMed ID: 33251149
[TBL] [Abstract][Full Text] [Related]
11. Abscisic acid regulates dormancy of prostate cancer disseminated tumor cells in the bone marrow.
Jung Y; Cackowski FC; Yumoto K; Decker AM; Wang Y; Hotchkin M; Lee E; Buttitta L; Taichman RS
Neoplasia; 2021 Jan; 23(1):102-111. PubMed ID: 33296752
[TBL] [Abstract][Full Text] [Related]
12. COVID-19-Induced Modifications in the Tumor Microenvironment: Do They Affect Cancer Reawakening and Metastatic Relapse?
Francescangeli F; De Angelis ML; Baiocchi M; Rossi R; Biffoni M; Zeuner A
Front Oncol; 2020; 10():592891. PubMed ID: 33194755
[TBL] [Abstract][Full Text] [Related]
13. AXL Is a Putative Tumor Suppressor and Dormancy Regulator in Prostate Cancer.
Axelrod HD; Valkenburg KC; Amend SR; Hicks JL; Parsana P; Torga G; DeMarzo AM; Pienta KJ
Mol Cancer Res; 2019 Feb; 17(2):356-369. PubMed ID: 30291220
[TBL] [Abstract][Full Text] [Related]
14. Tumor removal limits prostate cancer cell dissemination in bone and osteoblasts induce cancer cell dormancy through focal adhesion kinase.
Liu R; Su S; Xing J; Liu K; Zhao Y; Stangis M; Jacho DP; Yildirim-Ayan ED; Gatto-Weis CM; Chen B; Li X
J Exp Clin Cancer Res; 2023 Oct; 42(1):264. PubMed ID: 37821954
[TBL] [Abstract][Full Text] [Related]
15. Bone as a Preferential Site for Metastasis.
Sowder ME; Johnson RW
JBMR Plus; 2019 Mar; 3(3):e10126. PubMed ID: 30918918
[TBL] [Abstract][Full Text] [Related]
16. Forging New Therapeutic Targets: Efforts of Tumor Derived Exosomes to Prepare the Pre-Metastatic Niche for Cancer Cell Dissemination and Dormancy.
Bhatia R; Chang J; Munoz JL; Walker ND
Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371709
[TBL] [Abstract][Full Text] [Related]
17. The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.
Shiozawa Y; Berry JE; Eber MR; Jung Y; Yumoto K; Cackowski FC; Yoon HJ; Parsana P; Mehra R; Wang J; McGee S; Lee E; Nagrath S; Pienta KJ; Taichman RS
Oncotarget; 2016 Jul; 7(27):41217-41232. PubMed ID: 27172799
[TBL] [Abstract][Full Text] [Related]
18. Single-cell sequencing reveals MYC targeting gene MAD2L1 is associated with prostate cancer bone metastasis tumor dormancy.
Wang X; Yu J; Yan J; Peng K; Zhou H
BMC Urol; 2022 Mar; 22(1):37. PubMed ID: 35305591
[TBL] [Abstract][Full Text] [Related]
19. Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone.
Sharma S; Xing F; Liu Y; Wu K; Said N; Pochampally R; Shiozawa Y; Lin HK; Balaji KC; Watabe K
J Biol Chem; 2016 Sep; 291(37):19351-63. PubMed ID: 27422817
[TBL] [Abstract][Full Text] [Related]
20. Combined genome and transcriptome analysis of single disseminated cancer cells from bone marrow of prostate cancer patients reveals unexpected transcriptomes.
Gužvić M; Braun B; Ganzer R; Burger M; Nerlich M; Winkler S; Werner-Klein M; Czyż ZT; Polzer B; Klein CA
Cancer Res; 2014 Dec; 74(24):7383-94. PubMed ID: 25320011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
